drugset

drugset / Trial / NCT00002198

A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients

NCT00002198 ↗

Phase 1 Completed Glaxo Wellcome

Open-labelTreatment

Summary

The purpose of this study is to see how the body processes 1592U89 and ethanol (pure grain alcohol) when they are given together.

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Abacavir	Other / unclassified	—	—

Indications